Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global Forecast to 2020

When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding. The usage of hemostats must be quick, localized, and carefully regulated. Although, the usage of hemostats is not required until and unless the bleeding is heavy or the patient is suffering from congenital diseases or trauma defects.

The global hemostats market size is expected to reach USD 2.76 billion by 2020, at a CAGR of 6.2% from 2015 to 2020. Based on product type, the global market is segmented into thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats. The thrombin based hemostats segment dominates the market, and is projected to grow at a decent pace during the forecast period, in terms of value.

Based on geography, the global market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is the most dominant region in the global market, followed by Europe. The growth in the Americas hemostats market is attributed to the increase in number of surgical procedures. However, the market in Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. Increasing healthcare infrastructure along with rise in number of surgeries are propelling the growth of this market.

Some of the major players in the hemostats market are Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.).

Key stakeholders of this market includes:

• Regulatory Authorities (such as FDA and insurance providers)
• Biosurgery Product Manufacturers
• Associations and International Bodies
• Medical Device Companies
• Research and Consulting Firms
• Vendors and Service Providers

Scope of the Report

Market Segmentation, by Product Type:

• Thrombin-Based
• Oxidized Regenerated Cellulose Based Hemostats
• Combination hemostats
• Gelatin Based Hemostats
• Collagen Based Hemostats

Market Segmentation, by Region:

• Americas
• Europe
• Asia-Pacific
• Middle East and Africa

Customization Options

Product Analysis

• Usage pattern (in-depth trend analysis) of products (segment-wise)
• Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country- and sub segment-level

Regulatory Framework

• Listing the regulatory issues of major countries if they are adversely affecting the business/market/industry
• Studying the reimbursements and its related impact offered by the government

Competitive Intelligence

• Market share of region-specific players in the market
• Crucial developments and strategies of the key companies inculcated in their portfolio

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Segmentation & Coverage
    1.3 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Integrated Ecosystem of the Market
           2.1.1 Top-Down Approach
           2.1.2 Bottom-Up Approach
           2.1.3 Macro Indicator- Based Approach
           2.1.4 Unit Price Analysis
           2.1.5 Product Matrix
           2.1.6 Porter’s Five Forces Model
           2.1.7 Life Expectancy Rate
    2.2 Assumptions

3 Executive Summary (Page No. - 27)

4 Market Overview (Page No. - 28)
    4.1 Introduction
    4.2 Market Drivers and Inhibitors
    4.3 Key Market Dynamics

5 Hemostats Market, By Product Type (Page No. - 31)
    5.1 Introduction
           5.1.1 Thrombin Based Hemostats
           5.1.2 Oxidized Regenerated Cellulose Based Hemostats
           5.1.3 Combination Hemostats
           5.1.4 Gelatin Based Hemostats
           5.1.5 Collagen Based Hemostats

6 Hemostats Market, By Geography (Page No. - 41)
    6.1 Introduction
    6.2 Americas
           6.2.1 U.S.
           6.2.2 Canada
           6.2.3 Mexico
           6.2.4 Brazil
           6.2.5 Argentina
           6.2.6 Chile
           6.2.7 Colombia
           6.2.8 Paraguay
           6.2.9 Uruguay
    6.3 Europe
           6.3.1 Germany
           6.3.2 France
           6.3.3 U.K.
           6.3.4 Italy
           6.3.5 Spain
           6.3.6 Russia
           6.3.7 Switzerland
           6.3.8 The Netherlands
           6.3.9 Belgium
           6.3.10 Denmark
           6.3.11 Turkey
    6.4 Asia-Pacific
           6.4.1 Japan
           6.4.2 China
           6.4.3 India
           6.4.4 Australia
           6.4.5 Republic of Korea
           6.4.6 Thailand
           6.4.7 Singapore
           6.4.8 Vietnam
           6.4.9 Taiwan
           6.4.10 Malaysia
           6.4.11 Indonesia
           6.4.12 New Zealand
    6.5 Middle East & Africa (MEA)
           6.5.1 Egypt
           6.5.2 Saudi Arabia
           6.5.3 UAE
           6.5.4 Israel
           6.5.5 Oman
           6.5.6 Kuwait
           6.5.7 Zimbabwe
           6.5.8 Kenya
           6.5.9 Jordan
           6.5.10 Algeria
           6.5.11 Morocco
           6.5.12 Libya
           6.5.13 Tunisia
           6.5.14 Sudan
           6.5.15 South Africa
           6.5.16 Mauritius

7 Competitive Landscape (Page No. - 126)
    7.1 Company Share Analysis
           7.1.1 U.S
           7.1.2 Canada
           7.1.3 Brazil
           7.1.4 Germany
           7.1.5 France
           7.1.6 U.K.
           7.1.7 China
           7.1.8 India
           7.1.9 Japan
    7.2 Product Launches
    7.3 Mergers and Acquisitions
    7.4 Collaborations, Joint Agreements & Expansions, Partnerships
    7.5 Approvals, Alliances, Relocations & Licensing, and New Brand Strategy

8 Hemostats Market, By Company (Page No. - 135)
    8.1 Johnson & Johnson Services, Inc.
           8.1.1 Business Overview
           8.1.2 Key Financials
           8.1.3 Product and Service Offerings
           8.1.4 Related Developments
           8.1.5 MnM View
    8.2 C. R. Bard, Inc.
           8.2.1 Business Overview
           8.2.2 Key Financials
           8.2.3 Product and Service Offerings
           8.2.4 Related Developments
           8.2.5 MnM View
    8.3 Baxter
           8.3.1 Overview
           8.3.2 Key Financials
           8.3.3 Product and Service Offerings
           8.3.4 Related Developments
           8.3.5 MnM View
    8.4 B. Braun Melsungen Ag
           8.4.1 Business Overview
           8.4.2 Key Financials
           8.4.3 Products and Service Offerings
           8.4.4 Recent Developments
           8.4.5 MnM View
    8.5 Pfizer Inc.
           8.5.1 Business Overview
           8.5.2 Key Financials
           8.5.3 Products and Service Offerings
           8.5.4 Recent Developments
           8.5.5 MnM View
    8.6 Vascular Solutions, Inc.
           8.6.1 Business Overview
           8.6.2 Key Financials
           8.6.3 Products and Service Offerings
           8.6.4 Recent Developments
           8.6.5 MnM View
    8.7 Gelita Medical Gmbh
           8.7.1 Business Overview
           8.7.2 Products and Service Offerings
           8.7.3 Recent Developments
           8.7.4 MnM View
    8.8 Equimedical
           8.8.1 Business Overview
           8.8.2 Products and Service Offerings
           8.8.3 MnM View
    8.9 Integra Lifesciences Holdings Corporation
           8.9.1 Business Overview
           8.9.2 Key Financials
           8.9.3 Product and Service Offerings
           8.9.4 MnM View
    8.10 Z-Medica, LLC
           8.10.1 Business Overview
           8.10.2 Product and Service Offerings
           8.10.3 Related Developments
           8.10.4 MnM View
    8.11 Marine Polymer Technologies, Inc.
           8.11.1 Business Overview
           8.11.2 Product and Service Offerings
           8.11.3 MnM View

9 Appendix (Page No. - 157)
    9.1 Customization Options
           9.1.1 Regulatory Framework
           9.1.2 Impact Analysis
    9.2 Introducing RT: Real Time Market Intelligence
    9.3 Related Reports

List of Tables (199 Tables)

Table 1 Unit Price Analysis
Table 2 Hemostats Market: Drivers and Inhibitors
Table 3 Market, By Product Type, 2013-2020 (USD MN)
Table 4 Market, By Geography, 2013-2020 (USD MN)
Table 5 Collagen Based Hemostats Market, By Geography, 2013-2020 (USD MN)
Table 6 Thrombin Based Market, By Geography, 2013-2020 (USD MN)
Table 7 Gelatin Based Market, By Geography, 2013-2020 (USD MN)
Table 8 Combination Market, By Geography, 2013-2020 (USD MN)
Table 9 Oxidized Regeneration Collagen Based Market, By Geography, 2013-2020 (USD MN)
Table 10 Market, By Product Type, 2013 – 2020 (USD MN)
Table 11 Market, By Product Type, 2013–2020 (Units)
Table 12 Thrombin Based Market, By Geography, 2013–2020 (USD MN)
Table 13 Thrombin Based Market, By Geography, 2013 – 2020 (Units)
Table 14 Oxidized Regenerated Cellulose Based Market, By Geography, 2013–2020 (USD MN)
Table 15 Oxidized Regenerated Cellulose Based Market, By Geography, 2013 – 2020 (Units)
Table 16 Combination Market, By Geography, 2013–2020 (USD MN)
Table 17 Combination Market, By Geography, 2013 – 2020 (Units)
Table 18 Gelatin Based Market, By Geography, 2013–2020 (USD MN)
Table 19 Gelatin Based Market, By Geography, 2013 – 2020 (Units)
Table 20 Collagen Based Market, By Geography, 2013–2020 (USD MN)
Table 21 Collagen Based Market, By Geography, 2013 – 2020 (Units)
Table 22 Market, By Region, 2013-2020 (USD MN)
Table 23 Americas Market, By Country, 2013-2020 (USD MN)
Table 24 Americas Market, By Product Type, 2013-2020 (USD MN)
Table 25 U.S. Market, By Product Type, 2013-2020 (USD MN)
Table 26 U.S. Market, By Product Type, 2013-2020 (Units)
Table 27 U.S. Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 28 Canada Market, By Product Type, 2013-2020 (USD MN)
Table 29 Canada Market, By Product Type, 2013-2020 (Units)
Table 30 Canada Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 31 Mexico Market, By Product Type, 2013-2020 (USD MN)
Table 32 Mexico Market, By Product Type, 2013-2020 (Units)
Table 33 Mexico Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 34 Brazil Market, By Product Type, 2013-2020 (USD MN)
Table 35 Brazil Market, By Product Type, 2013-2020 (Units)
Table 36 Brazil Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 37 Argentina Market, By Product Type, 2013-2020 (USD MN)
Table 38 Argentina Market, By Product Type, 2013-2020 (Units)
Table 39 Argentina Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 40 Chile Market, By Product Type, 2013-2020 (USD MN)
Table 41 Chile Market, By Product Type, 2013-2020 (Units)
Table 42 Chile Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 43 Colombia Market, By Product Type, 2013-2020 (USD MN)
Table 44 Colombia Market, By Product Type, 2013-2020 (Units)
Table 45 Colombia Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 46 Paraguay Market, By Product Type, 2013-2020 (USD MN)
Table 47 Paraguay Market, By Product Type, 2013-2020 (Units)
Table 48 Paraguay Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 49 Uruguay Market, By Product Type, 2013-2020 (USD MN)
Table 50 Uruguay Market, By Product Type, 2013-2020 (Units)
Table 51 Uruguay Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 52 Europe Market, By Country, 2013-2020 (USD MN)
Table 53 Europe Market Value, By Product Type, 2013-2020 (USD MN)
Table 54 Germany Market, By Product Type, 2013-2020 (USD MN)
Table 55 Germany Market, By Product Type, 2013-2020 (Units)
Table 56 Germany Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 57 France Market, By Product Type, 2013-2020 (USD MN)
Table 58 France Market, By Product Type, 2013-2020 (Units)
Table 59 France Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 60 U.K. Market, By Product Type, 2013-2020 (USD MN)
Table 61 U.K. Market, By Product Type, 2013-2020 (Units)
Table 62 U.K. Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 63 Italy Market, By Product Type, 2013-2020 (USD MN)
Table 64 Italy Market, By Product Type, 2013-2020 (Units)
Table 65 Italy Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 66 Spain Market, By Product Type, 2013-2020 (USD MN)
Table 67 Spain Market, By Product Type, 2013-2020 (Units)
Table 68 Spain Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 69 Russia Market, By Product Type, 2013-2020 (USD MN)
Table 70 Russia Market, By Product Type, 2013-2020 (Units)
Table 71 Russia Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 72 Switzerland Market, By Product Type, 2013-2020 (USD MN)
Table 73 Switzerland Market, By Product Type, 2013-2020 (Units)
Table 74 Switzerland Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 75 The Netherlands Market, By Product Type, 2013-2020 (USD MN)
Table 76 The Netherlands Market, By Product Type, 2013-2020 (Units)
Table 77 The Netherlands Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 78 Belgium Market, By Product Type, 2013-2020 (USD MN)
Table 79 Belgium Market, By Product Type, 2013-2020 (Units)
Table 80 Belgium Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 81 Denmark Market, By Product Type, 2013-2020 (USD MN)
Table 82 Denmark Market, By Product Type, 2013-2020 (Units)
Table 83 Denmark Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 84 Turkey Market, By Product Type, 2013-2020 (USD MN)
Table 85 Turkey Market, By Product Type, 2013-2020 (Units)
Table 86 Turkey Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 87 Asia-Pacific Market, By Country, 2013-2020 (USD MN)
Table 88 Asia-Pacific Market, By Product Type, 2013-2020 (USD MN)
Table 89 Japan Market, By Product Type, 2013-2020 (USD MN)
Table 90 Japan Market, By Product Type, 2013-2020 (Units)
Table 91 Japan Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 92 China Market, By Product Type, 2013-2020 (USD MN)
Table 93 China Market, By Product Type, 2013-2020 (Units)
Table 94 China Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 95 India Market, By Product Type, 2013-2020 (USD MN)
Table 96 India Market, By Product Type, 2013-2020 (Units)
Table 97 India Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 98 Australia Market, By Product Type, 2013-2020 (USD MN)
Table 99 Australia Market, By Product Type, 2013-2020 (Units)
Table 100 Australia Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 101 Republic of Korea Market, By Product Type, 2013-2020 (USD MN)
Table 102 Republic of Korea Market, By Product Type, 2013-2020 (Units)
Table 103 Republic of Korea Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 104 Thailand Market, By Product Type, 2013-2020 (USD MN)
Table 105 Thailand Market, By Product Type, 2013-2020 (Units)
Table 106 Thailand Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 107 Singapore Market, By Product Type, 2013-2020 (USD MN)
Table 108 Singapore Market, By Product Type, 2013-2020 (Units)
Table 109 Singapore Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 110 Vietnam Market, By Product Type, 2013-2020 (USD MN)
Table 111 Vietnam Market, By Product Type, 2013-2020 (Units)
Table 112 Vietnam Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 113 Taiwan Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 114 Taiwan Hemostats Market, By Product Type, 2013-2020 (Units)
Table 115 Taiwan Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 116 Malaysia Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 117 Malaysia Hemostats Market, By Product Type, 2013-2020 (Units)
Table 118 Malaysia Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 119 Indonesia Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 120 Indonesia Hemostats Market, By Product Type, 2013-2020 (Units)
Table 121 Indonesia Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 122 New Zealand Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 123 New Zealand Hemostats Market, By Product Type, 2013-2020 (Units)
Table 124 New Zealand Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 125 Middle East & Africa Hemostats Market, By Country, 2013-2020 (USD MN)
Table 126 Middle East & Africa Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 127 Egypt Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 128 Egypt Hemostats Market, By Product Type, 2013-2020 (Units)
Table 129 Egypt Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 130 Saudi Arabia , By Product Type, 2013-2020 (USD MN)
Table 131 Saudi Arabia Hemostats Market, By Product Type, 2013-2020 (Units)
Table 132 Saudi Arabia Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 133 UAE Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 134 UAE Hemostats Market, By Product Type, 2013-2020 (Units)
Table 135 UAE Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 136 Israel Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 137 Israel Hemostats Market, By Product Type, 2013-2020 (Units)
Table 138 Israel Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 139 Oman Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 140 Oman Hemostats Market, By Product Type, 2013-2020 (Units)
Table 141 Oman Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 142 Kuwait Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 143 Kuwait Hemostats Market, By Product Type, 2013-2020 (Units)
Table 144 Kuwait Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 145 Zimbabwe Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 146 Zimbabwe Hemostats Market, By Product Type, 2013-2020 (Units)
Table 147 Zimbabwe Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 148 Kenya Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 149 Kenya Hemostats Market, By Product Type, 2013-2020 (Units)
Table 150 Kenya Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 151 Jordan Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 152 Jordan Hemostats Market, By Product Type, 2013-2020 (Units)
Table 153 Jordan Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 154 Algeria Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 155 Algeria Hemostats Market, By Product Type, 2013-2020 (Units)
Table 156 Algeria Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 157 Morocco Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 158 Morocco Hemostats Market, By Product Type, 2013-2020 (Units)
Table 159 Morocco Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 160 Libya Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 161 Libya Hemostats Market, By Product Type, 2013-2020 (Units)
Table 162 Libya Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 163 Tunisia Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 164 Tunisia Hemostats Market, By Product Type, 2013-2020 (Units)
Table 165 Tunisia Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 166 Sudan Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 167 Sudan Hemostats Market, By Product Type, 2013-2020 (Units)
Table 168 Sudan Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 169 South Africa Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 170 South Africa Hemostats Market, By Product Type, 2013-2020 (Units)
Table 171 South Africa Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 172 Mauritius Hemostats Market, By Product Type, 2013-2020 (USD MN)
Table 173 Mauritius Hemostats Market, By Product Type, 2013-2020 (Units)
Table 174 Mauritius Hemostats Market Average Selling Price, By Product Type, 2013-2020 (USD)
Table 175 Hemostats Market: Company Share Analysis, 2014 (%)
Table 176 Canada Hemostats Market: Company Share Analysis, 2014 (%)
Table 177 Brazil Hemostats Market: Company Share Analysis, 2014 (%)
Table 178 Germany Hemostats Market: Company Share Analysis, 2014 (%)
Table 179 France Hemostats Market: Company Share Analysis, 2014 (%)
Table 180 U.K. Hemostats Market: Company Share Analysis, 2014 (%)
Table 181 China Hemostats Market: Company Share Analysis, 2014 (%)
Table 182 India Hemostats Market: Company Share Analysis, 2014 (%)
Table 183 Japan Hemostats Market: Company Share Analysis, 2014
Table 184 Product Launches
Table 185 Mergers and Acquisitions
Table 186 Collaborations, Joint Agreements & Expansions, Partnerships
Table 187 Approvals, Alliances, Relocation & Licensing, and New Brand Strategy
Table 188 Johnson & Johnson Services, Inc.: Revenue, By Business Segment, 2011-2014 (USD MN)
Table 189 Johnson & Johnson Services, Inc.: Revenue, By Geographic Segment, 2011-2014 (USD MN)
Table 190 C. R. Bard, Inc.: Revenue, By Business Segments, 2010-2014 (USD MN)
Table 191 Baxter: Revenue, By Business Segments, 2010-2014 (USD MN)
Table 192 Baxter: Revenue, By Geographic Segment, 2010-2014 (USD MN)
Table 193 B. Braun Melsungen Ag: Revenue, By Businesss Segment, 2010-2014 (USD MN)
Table 194 B. Braun Melsungen Ag: Revenue, By Geographic Segment, 2010-2014 (USD MN)
Table 195 Pfizer Inc.: Revenue Mix, 2010-2014 (USD MN)
Table 196 Pfizer Inc.: Revenue, By Geographic Segment 2010-2014 (USD MN)
Table 197 Vascular Solutions, Inc.: Revenue, By Segment, 2010-2014 (USD MN)
Table 198 Vascular Solutions, Inc.: Revenue, By Geographic Segment, 2010-2014 (USD MN)
Table 199 Integra Lifesciences Holdings Corporation: Revenue, By Business Segment, 2011 - 2014 (USD MN)

List of Figures (90 Figures)

Figure 1 Hemostats Market Segmentation & Coverage
Figure 2 Hemostats Market: Integrated Ecosystem
Figure 3 Top-Down Approach
Figure 4 Bottom-Up Approach
Figure 5 Macro Indicator-Based Approach
Figure 6 Life Expectancy Rate
Figure 7 Hemostats Market Snapshot 2014
Figure 8 Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 9 Thrombin Based Hemostats Market, By Geography, 2015 & 2020 (USD MN)
Figure 10 Oxidized Regenerated Cellulose Based Hemostats Market, By Geography, 2015 & 2020 (USD MN)
Figure 11 Combination Hemostats Market, By Geography, 2015 & 2020 (USD MN)
Figure 12 Gelatin Based Hemostats Market, By Geography, 2015 & 2020 (USD MN)
Figure 13 Collagen Based Hemostats Market, By Geography, 2015 & 2020 (USD MN)
Figure 14 Hemostats Market, By Region, 2015 & 2020 (USD MN)
Figure 15 Americas Hemostats Market, By Country, 2014 & 2020 (USD MN)
Figure 16 Americas Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 17 U.S. Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 18 Canada Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 19 Mexico Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 20 Brazil Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 21 Argentina Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 22 Chile Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 23 Colombia Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 24 Paraguay Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 25 Uruguay Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 26 Europe Hemostats Market, By Country, 2014 & 2020 (USD MN)
Figure 27 Europe Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 28 Germany Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 29 France Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 30 U.K. Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 31 Italy Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 32 Spain Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 33 Russia Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 34 Switzerland Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 35 The Netherlands Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 36 Belgium Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 37 Denmark Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 38 Turkey Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 39 Asia-Pacific Hemostats Market, By Country, 2014 & 2020 (USD MN)
Figure 40 Asia-Pacific Hemostats Market Value, By Product Type, 2015 & 2020 (USD MN)
Figure 41 Japan Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 42 China Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 43 India Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 44 Australia Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 45 Republic of Korea Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 46 Thailand Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 47 Singapore Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 48 Vietnam Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 49 Taiwan Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 50 Malaysia Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 51 Indonesia Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 52 New Zealand Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 53 Middle East & Africa Hemostats Market, By Country, 2014 & 2020 (USD MN)
Figure 54 Middle East & Africa Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 55 Egypt Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 56 Saudi Arabia Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 57 UAE Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 58 Israel Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 59 OMAN Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 60 Kuwait Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 61 Zimbabwe Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 62 Kenya Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 63 Jordan Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 64 Algeria Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 65 Morocco Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 66 Libya Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 67 Tunisia Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 68 Sudan Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 69 South Africa Hemostats Market, By Product Type, 2015 & 2020 (USD MN)
Figure 70 Mauritius Hemostats Market, By Product Type, 2013-2020 (USD MN)
Figure 71 U.S. Hemostats Market: Company Share Analysis, 2014 (%)
Figure 72 Canada Hemostats Market: Company Share Analysis, 2014 (%)
Figure 73 Brazil Hemostats Market: Company Share Analysis, 2014 (%)
Figure 74 Germany Hemostats Market: Company Share Analysis, 2014 (%)
Figure 75 France Hemostats Market: Company Share Analysis, 2014 (%)
Figure 76 U.K. Hemostats Market: Company Share Analysis, 2014 (%)
Figure 77 China Hemostats Market: Company Share Analysis, 2014 (%)
Figure 78 India Hemostats Market: Company Share Analysis, 2014 (%)
Figure 79 Japan Hemostats Market: Company Share Analysis, 2014 (%)
Figure 80 Johnson & Johnson Services, Inc: Revenue Mix, 2014 (%)
Figure 81 Johnson & Johnson Services, Inc.: Revenue Mix, 2014 (%)
Figure 82 C. R. Bard, Inc.: Revenue Mix, 2014 (%)
Figure 83 Baxter: Revenue Mix, 2014 (%)
Figure 84 Baxter: Revenue Mix, 2010-2014 (%)
Figure 85 B. Braun Melsungen AG: Revenue Mix, 2014 (%)
Figure 86 B. Braun Melsungen AG: Revenue Mix, 2014 (%)
Figure 87 Pfizer Inc.: -Revenue Mix, 2014 (%)
Figure 88 Vascular Solutions, Inc.: Revenue Mix, 2014 (%)
Figure 89 Vascular Solutions, Inc.: Revenue Mix, 2014 (%)
Figure 90 Integra Lifesciences Holdings Corporation: Revenue Mix, 2014 (%)

The global hemostats market is projected to reach USD 2.76 Billion by 2020 at a CAGR of 6.2% from 2015 to 2020. The Americas market contributed the largest share to the global market in 2014, wherein the U.S. dominating the Americas market.

The report on global hemostats market analyzes and segments the market on the basis of product and region. It analyzes the competitive developments, such as alliances, joint ventures, and mergers & acquisitions in the global market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments.

Hemostats helps stop bleeding during surgeries (particularly during liver surgeries, cardiovascular surgeries, spine surgeries among others). It suppresses and stops the flow of blood from the particular site after surgery. It also prevents leaking of non-blood fluids and hence do not involve risks of post-operative infections like swelling of that particular area where hemostats are used. Hemostats has minimal invasive application and provides better visualization.

The driving forces for global market include consolidation of healthcare insurance providers, rise in initiatives take up by governments, and increasing number of surgery procedures. However, high cost of the hemostats hinders the growth of the market.

Based on product type, the global market is segmented into thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats. The thrombin based hemostats segment dominates the market and is projected to grow at a steady rate during the forecast period, in terms of value.

Gelatin based hemostats are one of the cheapest hemostats available in powder form. These products are majorly found in the Asia-Pacific market, especially in India. Oxidized regenerated cellulose based hemostats provides physical matrix for clotting. This products are fully absorbable within 7-14 days. One of the famous oxidized regenerated cellulose based hemostats are Surgicel ® by Ethicon LLC (by Johnson & Johnson Private Limited).

Some of the key players operating in the global hemostats market include Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.).